Lazanda (transmucosal immediate release fentanyl [TIRF]) is now available at a 300 mcg dose strength to treat breakthrough cancer pain.
Rotation to methadone as a second-line opioid may be safe and efficacious when using a tiered scheme with close follow-up in patients.
Low-dose morphine may effectively reduce pain intensity compared with weak opioids in patients with cancer who have moderate pain.
A single infusion of ibandronate had outcomes similar to a single dose of radiotherapy for metastatic bone pain in prostate cancer.
There are key factors to consider when determining the best treatment strategy for pain in patients with cancer.
Reciprocal relationship between cancer and neurons at play in cancer tumor proliferation and pain sensitization.
For early-stage breast cancer treated with aromatase inhibitors (AIs), arthralgia is improved with omega-3 fatty acid (O3-FA) and placebo.
Almost half of colorectal cancer (CRC) survivors with pain interference (PI) during the initial phase of care have continued PI post-treatment.
Sativex did not meet its primary endpoint in demonstrating statistically significant difference from placebo for patients with advanced cancer.
Treatment-related discomfort, swelling in breast cancer patients helped by acupuncture and exercise in two studies.
Successful management of severe cancer pain can be a challenge for oncologists and their patients.
This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.
In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.
Colon cancer survivors are more likely to suffer future lesions related with pain in the back and lower abdomen than healthy individuals of the same gender and age.
Oral malignancies can be associated with increased pain, but current research suggests that a cannabis-based spray may reduce this morbidity.
New MRI-guided focused ultrasound reduces pain from bone metastases.
Patients who receive radiotherapy for head and neck cancer may now have an effective way to combat pain from oral mucositis.
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Why do only one in six medical oncologists refer patients with cancer pain to palliative care or pain specialists?
Researchers are looking at new ways to determine pain levels in pediatric patients with cancer, and subsequently improving communication in all aspects of cancer care.
Clinical trial data bolster the case for repeat single-dose radiotherapy as preferred treatment for painful bone metastases.
EUS-CNB may offer a viable technique for managing pain in patients with pancreatic cancer.
Most women breast cancer treated with breast-conserving surgery or mastectomy with axillary surgery experience postoperative pain.
Inadequate pain management, baseline pain severity linked to pain deterioration
Studies suggest acupuncture may relieve pain and lymphedema in patients with cancer, but clinical trials are lacking.
Two recent studies demonstrate that microwave ablation offers rapid pain relief with few complications.
Managing pain as a result of cancer metastatic to the bone is an important element of a patient's overall treatment plan.
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
Sublingual Sufentanil NanoTabs Are Superior to IV Morphine for Acute Post-Surgical Pain Management, AcelRx AnnouncesNovember 19, 2012
Sublingual opioid sufentanil NanoTab PCA is superior to intravenous PCA morphine for post-surgical acute pain management.
The FDA announced the approval of InsighTec's ExAblate magnetic resonance imaging-guided focused ultrasound thermoablation system, the first device approved in the US for pain palliation in patients with bone metastasis.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- CAR-T Trial for Triple-Negative Breast Cancer Under Way
- Daratumumab Combination: New Standard of Care in Transplant-Ineligible Multiple Myeloma
- Adjuvant Trastuzumab Emtansine Confers Improved Outcome in KATHERINE Trial
- Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
- Extension of Adjuvant Anastrozole Regimen to 10 Years Yields Higher DFS, but Not OS
- Selinexor Trials Move Nuclear Suppressor Protein-Export Inhibition Closer to the Clinic for Multiple Myeloma
- Younger Breast Cancer Patients at Higher Risk for Osteoporosis
- Molecular Mechanisms Underlying Immunosurveillance in Multiple Myeloma Identified
- Gly101Val Mutation Directly Causes Resistance to Venetoclax
- Can Treatments for Childhood ALL Alter the Gut Microbiome?